Our Services
Medical Information
Helpful Resources
Published on: 9/26/2026
Dizziness on spironolactone usually comes from its diuretic and blood pressure lowering effects, which reduce fluid volume and can trigger a drop in pressure when you stand, along with electrolyte shifts such as rising potassium or falling sodium. Common prevention steps include taking your dose earlier in the day, rising slowly from sitting or lying down, staying adequately hydrated, avoiding salt substitutes and potassium supplements unless approved, limiting alcohol, and asking your prescriber to review your dose and other blood pressure medications. Timing, dosage, hydration, and lab monitoring all matter differently depending on why you are taking it, so see below for the full details before changing anything. Dizziness paired with fainting, palpitations, severe muscle weakness, or confusion can signal dangerously high potassium and needs prompt medical attention.
If you are unsure whether your dizziness is a manageable side effect or a warning sign, a free, instant, online symptom check can help you organize your symptoms and understand what to do next.
Last reviewed for medical accuracy: 09/26/2026
Spironolactone is a potassium‐sparing diuretic prescribed for high blood pressure, heart failure, hormonal acne and other conditions. By blocking aldosterone, it helps your body get rid of excess water and salt while retaining potassium. Although effective, one common side effect is dizziness or lightheadedness—and in some cases, fainting.
Dizziness typically arises from a drop in blood pressure (especially when standing up), reduced blood volume or shifts in electrolyte levels. Understanding why this happens and how to prevent it can help you stay safe and comfortable on spironolactone.
Lowered Blood Volume
• Spironolactone causes you to excrete sodium and water.
• Losing fluid can reduce circulating blood volume, leading to low blood pressure.
Orthostatic (Postural) Hypotension
• When you stand, gravity pulls blood into your legs.
• If your vessels don’t constrict fast enough, your brain gets less blood for a moment—causing dizziness.
Electrolyte Shifts
• Retained potassium is usually good, but if levels climb too high, you might feel weak or dizzy.
• Low sodium (hyponatremia) can also contribute.
Interaction with Other Medications
• Other blood pressure meds, antidepressants or some painkillers can amplify the drop in blood pressure.
• Always review all prescriptions and over‐the‐counter drugs with your doctor or pharmacist.
Certain factors make dizziness or fainting more likely:
Watch for these early symptoms of low blood pressure or volume depletion:
If you ever feel faint or notice these signs regularly, take action to prevent a fall or injury—and talk to a healthcare professional.
Here’s your step‐by‐step guide to reducing dizziness and avoiding fainting episodes:
• Limit alcohol and caffeine, both of which can worsen dehydration.
• Eat regular, balanced meals—low blood sugar can make dizziness feel worse.
• Keep cool—overheating can worsen fluid loss and pooling in your legs.
• Exercise gently—walking and light stretching encourage circulation without drastic blood pressure swings.
Certain symptoms require prompt evaluation:
If you experience any of these, speak to a doctor right away or call emergency services.
If you’re unsure whether your dizziness is serious, you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance and know when to get in touch with a professional.
Dizziness or fainting on spironolactone usually stems from low blood pressure or reduced blood volume. By adjusting how you take the drug, staying hydrated, and making simple lifestyle changes, you can greatly reduce these side effects. Always keep your healthcare provider in the loop—never adjust your dose or stop a medication without medical advice.
If you have any concerns—especially if your symptoms feel life‐threatening—please speak to a doctor as soon as possible.
(References)
* Yemisci A, Gorgulu A, Piskin S. Effects and side-effects of spironolactone therapy in women with acne. J Eur Acad Dermatol Venereol. 2005 Mar;19(2):163-6. doi: 10.1111/j.1468-3083.2005.01072.x. PMID: 15752283.
* Yaméogo NV, Samadoulougou AK, Kagambèga LJ, Millogo GR, Yaméogo AA, Kologo KJ, Ilboudo E, Kaboré E, Mandi G, Kombasséré K, Toguyeni BJ, Pignatelli S, Simporé J, Zabsonré P. [Epidemiological characteristics and clinical features of black African subject's resistant hypertension]. Ann Cardiol Angeiol (Paris). 2014 Apr;63(2):83-8. doi: 10.1016/j.ancard.2014.01.002. Epub 2014 Jan 21. PMID: 24492012.
* Gao Y, Yang J, Ma L, Zhang Y, Li Z, Wu L, Yang L, Wang H. Non-ST elevation myocardial infarction induced by carbon monoxide poisoning: A case report. Medicine (Baltimore). 2019 Apr;98(15):e15151. doi: 10.1097/MD.0000000000015151. PMID: 30985691; PMCID: PMC6485747.
* Diuretics. 2012. PMID: 31644115.
* Patiyasikunt M, Chancheewa B, Asawanonda P, Noppakun N, Kumtornrut C. Efficacy and tolerability of low-dose spironolactone and topical benzoyl peroxide in adult female acne: A randomized, double-blind, placebo-controlled trial. J Dermatol. 2020 Dec;47(12):1411-1416. doi: 10.1111/1346-8138.15559. Epub 2020 Aug 28. PMID: 32857471.
* Maia NPD, Lopes KC, Ganança FF. Otorhinolaryngological adverse effects of urological drugs. Int Braz J Urol. 2021 Jul-Aug;47(4):747-752. doi: 10.1590/S1677-5538.IBJU.2021.99.06. PMID: 33566468; PMCID: PMC8321485.
* Qiao Y, Zhao J, Wu J, Cao L, Song G, Mao J. Clinical and genetic analysis of a case of Gitelman syndrome accompanied with Graves disease and adrenocortical adenoma: A case report. Medicine (Baltimore). 2024 Apr 12;103(15):e37770. doi: 10.1097/MD.0000000000037770. PMID: 38608089; PMCID: PMC11018201.
* St Pierre K, Cashmore BA, Bolignano D, Zoccali C, Ruospo M, Craig JC, Strippoli GF, Mallett AJ, Green SC, Tunnicliffe DJ. Interventions for preventing the progression of autosomal dominant polycystic kidney disease. Cochrane Database Syst Rev. 2024 Oct 2;10(10):CD010294. doi: 10.1002/14651858.CD010294.pub3. Epub 2024 Oct 2. PMID: 39356039; PMCID: PMC11445802.
* Zidan BMRM, Zehravi M, Kareemulla S, Madhuri KSD, Gupta JK, Kumar VV, Khan J, Alkhathami AG, Osman H, Khandaker MU, Emran TB. High-altitude physiology: Understanding molecular, pharmacological and clinical insights. Pathol Res Pract. 2025 Aug;272:156080. doi: 10.1016/j.prp.2025.156080. Epub 2025 Jun 11. PMID: 40516140.
* Dewey E, Salloum L, Gregoire S, McIntosh BA, Zhao V, Mostaghimi A. Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study. J Am Acad Dermatol. 2026 Jun;94(6):1679-1685. doi: 10.1016/j.jaad.2026.02.003. Epub 2026 Feb 5. PMID: 41654020.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.